Supernus Pharmaceuticals
@supernus.com
Supernus, a biopharmaceutical company, develops CNS disease treatments. Transforming patient care with cutting-edge therapies and strategic partnerships.
Supernus Pharmaceuticals's Company Logos
Supernus Pharmaceuticals's Brand Colors
Hex Code
Color name
RGB
HSL
CMYK
#D5D859
Tacha
213, 216, 89
61, 62, 60
1, 0, 59, 15
#FFFFFF
White
255, 255, 255
0, 0, 100
0, 0, 0, 0
#143D71
Chathams Blue
20, 61, 113
214, 70, 26
82, 46, 0, 56
About Supernus Pharmaceuticals
Supernus Pharmaceuticals Inc. With over 30 years of experience in product development, they have established themselves as experts in the field. Supernus is dedicated to improving the lives of patients suffering from conditions such as ADHD, migraine, epilepsy, and Parkinson's disease.
Their portfolio includes a range of successful products that have made a significant impact on patients' lives. They market Qelbree® for ADHD, Trokendi XR® and Oxtellar XR® for migraine and epilepsy, Apokyn® and GOCOVRI® for Parkinson's disease, Myobloc® for cervical dystonia and chronic sialorrhea, Xadago® for PD patients, and Osmolex ER® for Parkinson's disease. Supernus is committed to shaping the future of CNS treatments by focusing on innovative solutions.
They strive for growth and profitability, advance product candidates toward commercialization, grow their pipeline, and target strategic business development opportunities. With a strong emphasis on integrity, commitment, innovation, and caring, Supernus Pharmaceuticals is dedicated to bettering the lives of patients and making a lasting impact in the field of CNS diseases
Company type
Public Company
Year founded
2005
Company size
201-500 employees
Related Brands
Tags
CNS biopharmaceuticals
Neurology and psychiatry therapeutics
Epilepsy drugs
Migraine treatments
ADHD medications
